Overall Survival and Treatment Outcome of Childhood ALL in Si Sa Ket hospital
Main Article Content
Abstract
Background: Acute Lymphoblastic leukemia (ALL) is the most common neoplasm in childhood. The probability of current overall survival (OS) is around 90% in developed countries. Major causes of death were severe infection during chemotherapy and relapse of disease.
Objective: This work aims to analyze the results of children with ALL treated at Si Sa Ket Hospital and to defined risk factors to achieved outcome.
Methods: Prognostic research, retrospective data collection of childhood ALL patients treated at Si Sa Ket Hospital with Thai-national based protocol (ThaiPOG) by risk classification group of patients . Kaplan-Meier was used for the analysis of OS and the Cox proportional hazards regression model for multivariate analysis.
Results: Fifty-three children with acute lymphoblastic leukemia were included in the study. Majority of them had age less than 5 years. The male to female ratio was 1.1:1. Most common subtype was pre-B cell ALL. The overall survival was 72.6 %. The Three-year survival rates by risk group were 79.4 %, 76.4 % and 42.9 % in the standard-risk, high-risk and very high-risk groups, respectively. The relapse rate was 13.2 % and mortality rate was 24.5%.
Conclusions: The overall survival of Childhood-ALL in Si Sa Ket hospital was lower than the developed country but higher than the study in Thailand which treated with ThaiPOG based protocol. Severe infection and relapse of disease were the majority cause of death.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev 2011;12(9):2215-20. PMID: 22296359
Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am 2015;62(1):47-60. doi: 10.1016/j.pcl.2014.09.004.
Lanzkowsky P, Lipton JM, Fish JD. Lanzkowsky’s manual of pediatric hematology and oncology. 6thed. London : Academic Press; 2016.
Pizzo P, Poplack D. Principles and Practice of Pediatric Oncology. 7th ed. Philadelphia: Wolters Kluwer; 2016.
Locatelli F, Schrappe M, Bernardo ME, Rutella S. How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012;120(14):2807-16. doi: 10.1182/blood-2012-02-265884.
ชมรมโรคมะเร็งเด็กแห่งประเทศไทย, สมาคมโลหิตวิทยาแห่งประเทศไทย, สำนักงานหลักประกันสุขภาพแห่งชาติ (สปสช.). แนวทางการรักษาโรคมะเร็งในเด็ก พ.ศ. 2561. กรุงเทพฯ : ชมรมโรคมะเร็งเด็กแห่งประเทศไทย; 2561.
Bunyatisai W, Jia-Mahasap B, Chitapanarux I. Treatment Outcomes of Acute Lymphoblastic Leukemia in both children and adults using the Thai Pediatric Oncology Group-based protocol at Chiang Mai University hospital. มะเร็งวิวัฒน์ วารสมาคมรังสีรักษาและมะเร็งวิทยาแห่งประเทศไทย 2562;25(1):12-28.
Wongmeerit P, Suwanrungruang K, Jetsrisuparb A, Komvilaisak P, Wiangnon S. Trends in Survival of Childhood Cancers in a University Hospital, Northeast Thailand, 19932012. Asian Pac J Cancer Prev 2016;17(7):3515-9. PMID: 27510002
Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols. Asian Pac J Cancer Prev 2015;16(11):4609-14. doi: 10.7314/apjcp.2015.16.11.4609.
Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol 2012;30(14):1663-9. doi: 10.1200/JCO.2011.37.8018.
Teachey DT, Pui CH. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol 2019;20(3):e142-e154. doi: 10.1016/S1470-2045(19)30031-2.
Chotsampancharoen T, Songthawee N, Chavananon S, Sripornsawan P, McNeil EB. Relapsed Childhood Acute Lymphoblastic Leukemia: Experience from a Single Tertiary Center in Thailand. Asian Pac J Cancer Prev 2022;23(10):3517-22. doi: 10.31557/APJCP.2022.23.10.3517.
Oskarsson T, Söderhäll S, Arvidson J, Forestier E, Montgomery S, Bottai M, et al. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. Haematologica 2016;101(1):68-76. doi: 10.3324/haematol.2015.131680.
Öztürk AP, Koç B, Zülfikar B. Acute Complications and Survival Analysis of Childhood Acute Lymphoblastic Leukemia: A 15-year Experience. Clin Lymphoma Myeloma Leuk 2021;21(1):e39-e47. doi: 10.1016/j.clml.2020.08.025.
Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India.
J Pediatr Hematol Oncol 2010;32(5):366-9. doi: 10.1097/MPH.0b013e3181e0d036.